<html lang="en"><meta name="viewport" content="width=device-width, initial-scale=1" /><head><!-- Global site tag (gtag.js) - Google Analytics --><script async src="https://www.googletagmanager.com/gtag/js?id=G-2VYEP6CXDE"></script><script> window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag("js", new Date());  gtag("config", "G-2VYEP6CXDE");</script><link rel="stylesheet" href="../init.css"></head><body><section class="css-ps9sjo e1q9n20l0"><div class="css-nxgt9g e1wpftot0"><span class="css-1pipetz e1mwh2nm0"><a data-analytics="sidebar:section" href="/united-states/">United States</a></span><span class="css-1wi1zzr e1kwye4o0"> | <!-- -->Horseshoe crabs</span></div><h1 class="css-1bo5zl0 eoacr0f0">In America, crab blood remains vital for drug- and vaccine-making</h1><h2 class="css-4vhs4z ecgqxun0">Most rich countries have already shifted to synthetic alternatives</h2></section><img id="myImg" src="../image/20220903_USP004.jpg" width="auto" height="200"><div class="css-qzz574 e15vdjh42"><p class="article__body-text article__body-text--dropcap" data-caps="initial"><span data-caps="initial">E</span><small>very april</small> in South Carolina, fishermen catch hundreds of horseshoe crabs as they crawl onto shore to mate. The crustaceans are transported to labs owned by Charles River, an American pharmaceutical company, in Charleston. There they are strapped to steel countertops and, still alive, drained of about a third of their blue-coloured blood. Then they are returned to the ocean. This liquid is vital for America’s biomedical industry. A litre of it goes for as much as $15,000.</p><style data-emotion="css drxevm">.css-drxevm{margin:1.3125rem 0 2.1875rem;}.css-drxevm figure{margin:0;min-width:100%;}.css-drxevm figure figcaption{display:inline;font-size:var(--ds-type-scale-0);}.css-drxevm audio{display:block;margin-top:0.75rem;width:100%;}.css-drxevm +figure,.css-drxevm +.g-fallback+figure{margin-top:0;}</style><div class="css-drxevm e1xre6611"><figure><div><figcaption>Listen to this story.</figcaption> <style data-emotion="css 1fs0t47">.css-1fs0t47{display:inline;font-family:var(--ds-type-system-sans);font-size:var(--ds-type-scale-0);font-style:normal;font-weight:400;line-height:var(--ds-type-leading-border-link);}.css-1fs0t47 a{color:var(--ds-color-london-5);-webkit-text-decoration:underline;text-decoration:underline;text-underline-offset:0.125rem;-webkit-transition:color var(--ds-interactions-transition),color var(--ds-interactions-transition);transition:color var(--ds-interactions-transition),color var(--ds-interactions-transition);}.css-1fs0t47 a:hover{color:var(--ds-color-chicago-30);}.css-1fs0t47 a:focus{text-decoration-color:transparent;box-shadow:0 0 0 0.125rem var(--ds-color-hong-kong-55);outline:solid transparent;}.css-1fs0t47 a:active{text-decoration-color:var(--ds-color-hong-kong-55);box-shadow:none;color:var(--ds-color-london-5);}</style><span class="css-1fs0t47 e1ncjrms0">Enjoy more audio and podcasts on<!-- --> <a href="https://economist-app.onelink.me/d2eC/bed1b25" id="audio-ios-cta" rel="noreferrer" target="_blank">iOS</a> <!-- -->or<!-- --> <a href="https://economist-app.onelink.me/d2eC/7f3c199" id="audio-android-cta" rel="noreferrer" target="_blank">Android</a>.</span></div><audio class="react-audio-player" controls="" controlslist="nodownload" id="audio-player" preload="none" src="https://www.economist.com/media-assets/audio/019%20United%20States%20-%20Horseshoe%20crabs-86dedbbebea6875ef22c6214b1d81111.mp3" title="In America, crab blood remains vital for drug- and vaccine-making"><p>Your browser does not support the &lt;audio&gt; element.</p></audio><style data-emotion="css 1tbn2ub">.css-1tbn2ub{text-align:center;height:0;}.css-1tbn2ub>div{top:-0.625rem;}</style><div class="css-1tbn2ub e1xre6610"><style data-emotion="css sl0bi6">.css-sl0bi6{position:relative;display:inline-block;text-align:left;}</style><div class="css-sl0bi6 ey1yhxa8"><style data-emotion="css 1sbpzh1">.css-1sbpzh1{z-index:95;height:40px;width:40px;position:absolute;border-radius:50%;box-shadow:0 0 0 0 rgba(0, 0, 0, 1);-webkit-transform:scale(1);-moz-transform:scale(1);-ms-transform:scale(1);transform:scale(1);-webkit-animation:pulse-color 2s infinite;animation:pulse-color 2s infinite;}.css-1sbpzh1 circle{stroke:var(--ds-color-new-york-55);opacity:0.6;}@media (max-width: 22.4375rem){.css-1sbpzh1{top:calc(100% - 20px);left:calc(50% - 20px);}}@media (min-width: 22.5rem){.css-1sbpzh1{top:calc(100% - 20px);left:calc(50% - 20px);}}@-webkit-keyframes pulse-color{0%{-webkit-transform:scale(0.95);-moz-transform:scale(0.95);-ms-transform:scale(0.95);transform:scale(0.95);box-shadow:0 0 0 0 rgba(249, 195, 31, 0.7);}70%{-webkit-transform:scale(1);-moz-transform:scale(1);-ms-transform:scale(1);transform:scale(1);box-shadow:0 0 0 10px rgba(249, 195, 31, 0);}100%{-webkit-transform:scale(0.95);-moz-transform:scale(0.95);-ms-transform:scale(0.95);transform:scale(0.95);box-shadow:0 0 0 0 rgba(249, 195, 31, 0);}}@keyframes pulse-color{0%{-webkit-transform:scale(0.95);-moz-transform:scale(0.95);-ms-transform:scale(0.95);transform:scale(0.95);box-shadow:0 0 0 0 rgba(249, 195, 31, 0.7);}70%{-webkit-transform:scale(1);-moz-transform:scale(1);-ms-transform:scale(1);transform:scale(1);box-shadow:0 0 0 10px rgba(249, 195, 31, 0);}100%{-webkit-transform:scale(0.95);-moz-transform:scale(0.95);-ms-transform:scale(0.95);transform:scale(0.95);box-shadow:0 0 0 0 rgba(249, 195, 31, 0);}}</style><div class="css-1sbpzh1 ey1yhxa6"><svg aria-hidden="true" viewbox="0 0 100 100" xmlns="http://www.w3.org/2000/svg"><circle cx="50" cy="50" fill="transparent" r="18" stroke-width="12"></circle><circle cx="50" cy="50" fill="transparent" r="38" stroke-width="12"></circle></svg></div><style data-emotion="css cwcadi">.css-cwcadi{z-index:96;position:absolute;}@media (max-width: 22.4375rem){.css-cwcadi{top:100%;left:calc(50% - 130px);}}@media (min-width: 22.5rem){.css-cwcadi{top:100%;left:calc(50% - 130px);}}</style><div class="css-cwcadi ey1yhxa7"><style data-emotion="css 12d2uoj">.css-12d2uoj{box-sizing:border-box;background-color:white;font-family:var(--ds-type-system-sans);display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;gap:0.75rem;-webkit-flex-direction:column;-ms-flex-direction:column;flex-direction:column;padding:1.5rem;-webkit-filter:drop-shadow(rgba(0, 0, 0, 0.15) 0 4px 16px);filter:drop-shadow(rgba(0, 0, 0, 0.15) 0 4px 16px);border-color:var(--ds-color-london-85);border:1px solid var(--ds-color-los-angeles-85);border-radius:0.5rem;width:260px;}</style><div class="css-12d2uoj ey1yhxa5"><style data-emotion="css 4c6dm7">.css-4c6dm7{display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-flex-direction:row;-ms-flex-direction:row;flex-direction:row;-webkit-box-pack:justify;-webkit-justify-content:space-between;justify-content:space-between;}</style><div class="css-4c6dm7 ey1yhxa4"><style data-emotion="css t9wkhq">.css-t9wkhq{color:var(--ds-color-london-5);display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-align-items:end;-webkit-box-align:end;-ms-flex-align:end;align-items:end;font-size:var(--ds-type-scale-2);font-weight:500;line-height:var(--ds-type-leading-lower);}</style><div class="css-t9wkhq ey1yhxa3">Listen to this story</div><style data-emotion="css 1d5zrco">.css-1d5zrco{display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-flex-direction:column;-ms-flex-direction:column;flex-direction:column;-webkit-box-pack:center;-ms-flex-pack:center;-webkit-justify-content:center;justify-content:center;color:var(--ds-color-london-20);}.css-1d5zrco>button{height:24px;width:24px;}.css-1d5zrco>button .path-background{fill:var(--ds-color-london-35);}</style><div class="css-1d5zrco ey1yhxa2"><button aria-label="Close" class="ds-control-close _close" type="button"><svg viewbox="5 5 14 14" width="100%" xmlns="http://www.w3.org/2000/svg"><path class="path-background" d="M19 6.41L17.59 5 12 10.59 6.41 5 5 6.41 10.59 12 5 17.59 6.41 19 12 13.41 17.59 19 19 17.59 13.41 12z"></path></svg></button></div></div><style data-emotion="css 1mts01m">.css-1mts01m{color:var(--ds-color-london-35);font-size:var(--ds-type-scale--1);line-height:var(--ds-type-leading-lower);margin-bottom:1rem;font-weight:400;}</style><div class="css-1mts01m ey1yhxa1"><span>Save time by listening to our audio articles as you multitask</span></div><style data-emotion="css 1cosuf1">.css-1cosuf1{display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-flex-direction:row;-ms-flex-direction:row;flex-direction:row;-webkit-box-pack:justify;-webkit-justify-content:space-between;justify-content:space-between;}.css-1cosuf1>.ds-navigation-link>span{font-size:var(--ds-type-scale-0);line-height:var(--ds-type-leading-upper);color:var(--ds-color-london-35);border-bottom:1px solid var(--ds-color-london-35);}</style><div class="css-1cosuf1 ey1yhxa0"><button class="ds-slim-button" type="button">OK</button></div></div></div></div></div></figure></div><p class="article__body-text">Parts of modern medicine have been unusually reliant on the horseshoe crab. Its blood is the only known natural source of limulus amebocyte lysate (<small>lal</small>), an extract that detects endotoxin, a nasty and sometimes fatal bacterium. Drug firms use it to ensure the safety of medicines and implanted devices, including antibiotics, anti-cancer drugs, heart stents, insulin and vaccines. The immune cells in the crab’s blood clot around toxic bacteria, giving a visual signal of unwanted contamination.</p><p class="article__body-text">As pharmaceutical companies ramped up production of the covid-19 jab, demand for the blue liquid soared. In 2020 nearly 650,000 crabs were bled in America, 36% more than in 2018.</p><div class="adComponent_advert__Zm3SL adComponent_incontent__2NeL8 adComponent_hidden__2l1Bb advert--inline"><div><div class="adComponent_adcontainer__3UKZz" id="econ-1"></div></div></div><p class="article__body-text">Bleeding is not without harm to the crabs. Conservationists estimate that between 5% and 30% of them die on release. Biologists at the University of New Hampshire have found that, once bled, females become lethargic and have trouble following the tides to egg-laying areas. According to the Wetlands Institute, a non-profit group, the number of horseshoe crabs in Delaware Bay, where the Atlantic variety spawns, has declined by 90% over the past 15 years. </p><p class="article__body-text">In 2016 the International Union for Conservation of Nature listed them as “vulnerable” to extinction. It blamed overharvesting for use as food, bait and biomedical testing, as well as habitat loss. This also hurts other species. The red knot, a bird that migrates from South America to the Arctic tundra, is endangered largely because of the decline in horseshoe-crab eggs in Delaware Bay, a stopover.</p><p class="article__body-text">As crab numbers fall and demand for <small>lal</small> rises, America’s biomedical industry will face a crunch. Billions of covid-19 vaccinations have relied on it, but so do plenty of routine surgical procedures such as hip replacements, whose numbers are growing. Charles River, one of four manufacturers of <small>lal </small>in America, estimates that 55% of injectable pharmaceuticals and implanted devices globally are tested using the extract produced at their facility in Charleston.</p><p class="article__body-text">Yet a synthetic alternative to <small>lal</small> is already available, which in Europe is rapidly replacing crab blood as the industry standard for testing. In 2003 Lonza, a Swiss biotech company, cloned crab <small>dna</small> to create recombinant Factor <small>c</small> (r<small>fc</small>). Troubled by the red knot’s decline, Jay Bolden, an avid birdwatcher and biologist, pioneered the use of r<small>fc</small> in America at Eli Lilly, a pharmaceutical company. In a study published in 2017 Mr Bolden found that r<small>fc</small> detected endotoxins as well as <small>lal</small>, or even better. The test turned up fewer false positives and, moreover, was cheaper to produce.</p><div class="adComponent_advert__Zm3SL adComponent_incontent__2NeL8 adComponent_hidden__2l1Bb advert--inline"><div><div class="adComponent_adcontainer__3UKZz" id="econ-2"></div></div></div><p class="article__body-text">That year Eli Lilly vowed to test all new products with r<small>fc</small>; 80% of the company now uses it instead of <small>lal</small>. Sanofi, a French pharmaceutical firm, is also making the switch at their American plants. In 2018 America’s Food and Drug Administration (<small>fda</small>) approved the first medicine tested with r<small>fc</small>. Six more of Eli Lilly’s have since been authorised.</p><p class="article__body-text">In Europe, China and Japan, pharmacopoeias list r<small>fc</small> among their approved endotoxin-testing agents. But the <small>us</small> Pharmacopeia (<small>usp</small>), a non-profit that helps set medical quality standards on which the <small>fda</small> relies, has been reluctant to add the synthetic substance to its list. That means American firms that want to use r<small>fc</small> tests must work harder to prove their safety to the <small>fda</small>. To explain its hesitation, <small>usp</small> says that “one adverse incident might not only set back the adoption of r<small>fc</small> but could damage overall trust in vaccines or other injectables, already plagued by misinformation.”</p><p class="article__body-text">That holdup comes with its own costs. Barbara Brummer, who previously worked at Johnson &amp; Johnson and is now with the Nature Conservancy, an <small>ngo</small>, sums it up: “We are doing damage to an endangered population and not using an alternative that is equally effective and could be mass-produced” more cheaply. </p><p class="article__body-text">Charles River argues that supply fears are overblown, and that bleeding does little harm to crabs; it has been a vocal critic of the synthetic option, on safety grounds. But if <small>usp</small> approved synthetic testing, Mr Bolden reckons America’s other drug companies would swiftly turn away from <small>lal</small>. The next several rounds of covid-19 boosters produced in America will rely on the horseshoe crab. But such vampire-like dependence on its blue blood cannot last much longer. <span data-ornament="ufinish">■</span></p><p class="article__body-text"><i>For exclusive insight and reading recommendations from our correspondents in America, <a href="./page-not-found.html">sign up to Checks and Balance</a>, our weekly newsletter.</i></p></div></body></html>